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DDiscussion
Dr Thomas J. Gleason (Pittsburgh, Pa). I have no disclosures.
First, I congratulate de Kerchove and colleagues for an outstanding
presentation, and I thank them for supplying me with the manu-
script early, as I enjoyed reading it very much.
I strongly agree with the concept that BAV repair in combina-
tion with a reimplantation technique offers the best bicuspid valve
repair. In that context, I have followed Dr El Khoury’s work for the
last many years with great interest, and this study is yet another ex-
ample of his fine skill as a surgeon and his careful review of his
ownwork. These operations can be quite intellectually challenging
with respect to knowing what to do with the cusps and the annulus
and what not to do in a given case, and I commend your group in
doing so with no operative mortality and very low morbidity. Be-
yond these acknowledgements, I have 4 distinct questions, which
perhaps we should address 1 at a time.
Most of the failures were listed as due to cusp prolapse, and the
explanation of insufficiency was explained as a process of delayed
and progressive dilatation at the VAJ, with a mean increase among
the failures of 4.4 mm. If, however, there were simply dilatation of
the VAJ, or, to use Sir Magdi Yacoub’s term, the ‘‘surgical annu-
lus,’’ then it would seem that most patients could undergo rerepair
with reimplantation of the valve. Yet only 2 of the 9 affected pa-
tients underwent subsequent reimplantation. Were there also con-
comitant cusp issues at the time of reoperation, and if so, what
were they?
Dr de Kerchove. Thank you, Dr Gleason, for your very kind
comment and for this first pertinent question. The reoperation after
a previous aortic valve repair is a very different situation from that
of a first aortic valve repair. First, in reoperation, cusp issues may
coexist with VAJ dilatation. For example, in this series, 1 patient
had focal cusp calcification and another required primary repair
with a pericardial patch. In such situations, simple rerepair is ob-
viously contraindicated. Second, at reoperation, patients may be
7 to 10 years older and thus may be better candidates for biopros-
thetic replacement, rather than for valve repair. Third, after a first
repair, patients are not always agreeable to undergo a second re-
pair. And finally, in addition to those cusp or patient issues that
make rerepair feasible or not, we have to recognize that the under-
standing of the mechanism of failure and the confidence within the
reimplantation technique are relatively recent. Rerepair with reim-
plantation was only used twice in the most recent reoperative
cases. With the encouraging early outcomes that we obtainedThe Journal of Thoracic and Carwith those last reoperations, we certainly will continue to propose
reimplantation in cases of repair failure when it is justified.
Dr Gleason. Second, you do not show all of the follow-up
echocardiographic data, giving only the rate of 3+ or greater AI
at late follow-up. How many patients in the 2 groups had 1 or
2+ AI at follow-up, and was there a recurrent pattern of repair ma-
neuver or maneuvers that had a propensity toward recurrent AI of
any degree, be it mild or moderate? I suspect that we could learn
a lot from these data as well. What have you learned about what
other issues, whether cusp, aortic, or technically related, portend
a higher rate of failure beyond simply dilatation of the surgical
annulus?
Dr de Kerchove. This study was designed to compare the clin-
ical outcomes of the 2 groups, and we therefore examined only end
points representative of severe repair failure, a clinical outcome
such as aortic valve reoperation and the recurrence of severe AI.
We didn’t look at the mechanism of AI in patients with mild to
moderate recurrent AI.We built on a Kaplan-Meier curve for mod-
erate or greater recurrent AI, and we observed that the advantage
for the reimplantation group was evenmore statistically significant
by using this end point. This result supports our hypothesis regard-
ing the cause of repair failure in patients without circumferential
ventriculoaortic annuloplasty; however, we agree that it does not
explore the role of other cusp or technical issues in recurrent AI.
We are currently doing echocardiographic studies with this co-
hort of patients in which root dimensions and cusp function are an-
alyzed with time. The objective is to discover the technical or
morphologic factors related to recurrent AI.
Dr Gleason. Third, could you provide us with a bit more detail
with respect to your concept of annuloplasty associated with your
specific reimplantation technique? My interpretation of your de-
scription is that you are placing your primary sutures through
the surgical annulus or the VAJ in a manner similar to what Dr Da-
vid described years ago. I think that this technique is more of an
annular support than an annuloplasty, because one does not neces-
sarily change the anatomic annular shape with this technique.
My own view is that what is critical to a durable repair is the
concomitant correction of the primary angle of the subcommissu-
ral triangle back to a more acute angle, restoring anatomic annular
geometry in cases where there is annuloaortic ectasia of any signif-
icance. In other words, one must reconfigure the anatomic annulus
or the hinge point of the cusps to where they were when the valve
was competent earlier in that patient’s life. Are you changing the
shape of the anatomic annulus in the areas of the subcommissural
triangles with your technique, or are you simply supporting the an-
nulus to prevent subsequent dilatation?
Dr de Kerchove. I agree with you in considering that the reim-
plantation technique provides only a support of the VAJ when only
3 to 6 stitches are used for the proximal suture line. In our tech-
nique, however, the proximal suture line is more like a true annu-
loplasty. Effectively, we kept the original technique and we use 10
to 12 stitches for the proximal suture line. The compression exer-
cised by each stitch induces circumferential remodeling of the
VAJ. The decrease in the VAJ diameter is approximately 5 mm.
It is possible to adjust the remodeling or annuloplasty effect by
adapting the width of the stitches and the strength used to tie
them. For example, in type 0 bicuspid valve, where the valve is
asymmetric, we place the stitches symmetrically under both cuspsdiovascular Surgery c Volume 142, Number 6 1437
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Dto respect the valve morphology. At the opposite extreme, in a type
1 bicuspid valve, where the valve is generally asymmetric with the
conjoint cusp being larger, we place wider stitches under the con-
joint cusp than under the opposite cusp to perform a greater annu-
lar compression at this level. This annuloplasty associated with
symmetric reimplantation of the commissures has 2 advantages
in our opinion. One advantage is that you decrease the tension
on the conjoint cusp, which will facilitate repair of the raphe
and decrease the need for patch augmentation. The second advan-
tage is that you give the valve more symmetry, which seems to im-
prove durability of the repair, as suggested by Dr Sch€afers in
a recent publication.
Dr Gleason. Finally, I am intrigued by your protocol that aims
for a 5-mm coaptation length or depth at the midportion, because,
as you know, the coaptation length of a normal aortic valve and
a normally functioning BAV is nowhere near 5 mm but much
closer to 1 to 2 mm. I suspect that if we aim for a 5-mm coaptation,
likening it to goals of mitral valve repair—that is, that more coap-
tation is better—we will see much more aortic cusp sclerosis with
time along the leading edge, such as you may have seen in the 2
patients who had subsequent development of aortic stenosis at
years 7 and 8. Could you please explain why you do not aim for
a more anatomic correction but rather for this ‘‘overcorrection’’?
Dr de Kerchove. I agree with you regarding the negative im-
pact of overcorrection on repair durability. The 5-mm cutoff length
to which you make reference has been found in an echocardio-
graphic study from our team. In this study, we looked for echocar-
diographic parameters of tricuspid aortic valve and BAV repair
failure. We found that a coaptation length less than 4 mm, the pres-
ence of an eccentric regurgitant jet, and a valve coaptation below
the level of the annulus were independent predictors of late failure.
Currently, we place the greatest importance on the level of coapta-
tion. So if the valve is above the plane of the VAJ and the top of the
coaptation reaches the midpoint of the sinuses of Valsalva, I agree
with you that you don’t need a coaptation length as long as 5 mm.
In some cases, when you end up with some degree of valve billow-
ing, meaning that a portion of the body of the cusp is below the
plane of the VAJ, we think that a 5-mm coaptation provides greater
security for long-term durability, rather than being a sign of pro-
lapse overcorrection.
Dr Gleason. I would argue that the means to eliminate that ex-
act issue would be a proper annuloplasty, and that is really my
point, in that in lieu of a proper annuloplasty, one can create
a more redundant coaptation depth, but this may in fact impart de-
layed failure down the road.1438 The Journal of Thoracic and Cardiovascular SurDr de Kerchove. I agree with you that the role of annuloplasty
is primal.
Dr Michael P. Siegenthaler (Bethesda, Md). Some of your
patients had mild to moderate aortic stenosis after these repairs.
What is the natural history if you look at those patients long
term? Does it stay the same, or do some of them have calcifica-
tion? What was your observation with these mildly stenotic
repaired BAVs?
Dr de Kerchove. For mild or moderate stenosis induced by the
repair, most of the gradients remained stable with time, especially
when patients were young with no cusp calcification at all at the
time of repair. In older patients, or those with calcification at the
time of the repair, the risk of observing progressive increase of gra-
dients is real. At this stage of the follow-up, however, valve steno-
sis represents only 10% of the late failures, and reoperation for
stenosis was performed after 8 years, showing that the valve calci-
fication is a relatively slow process.
Dr Tirone E. David (Toronto, Ontario, Canada). This article is
too important to let go by without a remark. Repair of BAVis much
more complex than repair of tricuspid aortic valve, and those pres-
ent here who do this operation know that. Dr Gleason raised some
very important issues about the annuloplasty. The dilatation of the
aortic annulus is not symmetric. It is almost entirely on the fibrous
skeleton of the outflow tract, and as it dilates, the fibrous skeleton
sinks in on the mitral valve. The level of the false commissure is
thus much higher than the posterior annulus. How do you compen-
sate for that during reimplantation of the aortic valve? Dr El
Khoury, that is a bit unfair to him.
Dr El Khoury. In type 1, I agree that there is a difference in the
level. What we do is we try by sparing surgery first to have a really
180 repair. Now, the second issue is, and I agree with you that we
should see what to do with the false commissure. Now, if you im-
plant it at the same level, you will have a lack of tissue, because the
valvewill be like that [hand gesture]. Sowhy we try to put it a little
bit like that [hand gesture] to have this coaptation at this level. So
we respect it a little bit. But Dr Gleason’s point is very well taken.
If you close the subcommissural triangle, you do this naturally by
making the angle more acute, as opposed to obtuse. In type 1, the
formation of the angle is asymmetric; it is like that [hand gesture].
So we try to make it this way [hand gesture]. But the risk is if you
put it very low, you will have a valve flapping like that [hand ges-
ture]. So we put it a little bit higher to have the same level of
coaptation.
Dr David. He underscores what I said again. It is not a simple
repair; reimplantation of BAV is not simple.gery c December 2011
